UPDATED May 14, 2024
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SLV | zł69.70 | -0.4% | -9.2% | zł1.3b | zł68.98 | PE18.3x | E12.2% | n/a | ||
RVU | zł52.00 | 2.0% | -15.4% | zł1.2b | zł73.13 | PS17.9x | E-10.7% | n/a | ||
CLN | zł16.82 | 6.7% | 20.1% | zł858.8m | zł16.93 | PS4x | E98.8% | 0.5% | ||
MAB | zł18.20 | 9.9% | 2.2% | zł294.2m | zł15.83 | PE7.1x | E-103.2% | n/a | ||
MOC | zł15.38 | 8.2% | -29.4% | zł258.9m | zł34.00 | PS188.2x | E-6.3% | n/a | ||
RDG | zł5.10 | -1.9% | 52.7% | zł60.1m | n/a | PS6x | n/a | n/a | ||
BGD | zł22.80 | -3.4% | 52.0% | zł56.0m | n/a | PE13.3x | n/a | 1.8% | ||
PUR | zł7.41 | 0.1% | -57.0% | zł24.7m | n/a | PS226.2x | n/a | n/a | ||
GX1 | zł6.40 | -7.0% | -34.0% | zł21.1m | n/a | PS8.8x | n/a | 0% | ||
LCN | zł0.42 | -0.7% | -11.4% | zł8.9m | n/a | PS539x | n/a | n/a |